Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 449

1.

Survival Analyses of Metastatic Renal Cancer Patients Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study.

Hanna N, Sun M, Meyer CP, Nguyen PL, Pal SK, Chang SL, de Velasco G, Trinh QD, Choueiri TK.

J Clin Oncol. 2016 Jun 20. pii: JCO667931. [Epub ahead of print]

PMID:
27325852
2.

PET/CT in Head-neck Malignancies: The Implications for Personalized Clinical Practice.

Wassef HR, Hanna N, Colletti P.

PET Clin. 2016 Jul;11(3):219-32. doi: 10.1016/j.cpet.2016.02.002. Review.

PMID:
27321027
3.

Efficacy of High-Intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis From the National Cancer Data Base.

Seisen T, Sun M, Leow JJ, Preston MA, Cole AP, Gelpi-Hammerschmidt F, Hanna N, Meyer CP, Kibel AS, Lipsitz SR, Nguyen PL, Bellmunt J, Choueiri TK, Trinh QD.

J Clin Oncol. 2016 Jun 6. pii: JCO667352. [Epub ahead of print]

PMID:
27269944
4.

Frequencies, bandwidths and magnitudes of vocal tract and surrounding tissue resonances, measured through the lips during phonation.

Hanna N, Smith J, Wolfe J.

J Acoust Soc Am. 2016 May;139(5):2924. doi: 10.1121/1.4948754.

PMID:
27250184
5.

Sequential Therapies and the Cost-Effectiveness of Treating Metastatic Colon Cancer Patients.

Woldemichael A, Onukwugha E, Seal B, Hanna N, Mullins CD.

J Manag Care Spec Pharm. 2016 Jun;22(6):628-39. doi: 10.18553/jmcp.2016.22.6.628.

6.

A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.

Yang S, He P, Wang J, Schetter A, Tang W, Funamizu N, Yanaga K, Uwagawa T, Satoskar AR, Gaedcke J, Bernhardt M, Ghadimi BM, Gaida MM, Bergmann F, Werner J, Ried T, Hanna N, Alexander HR, Hussain SP.

Cancer Res. 2016 Apr 20. [Epub ahead of print]

PMID:
27197190
7.

Patterns of Biologics Use Across Treatment Lines in Elderly (Age >65) Medicare Patients With Metastatic Colon Cancer.

Bikov KA, Mullins CD, Hung A, Seal B, Onukwugha E, Hanna N.

Oncologist. 2016 Jun;21(6):676-83. doi: 10.1634/theoncologist.2015-0199. Epub 2016 Apr 28.

PMID:
27125751
8.

Factors Affecting Gender-based Experiences for Residents in Radiation Oncology.

Barry PN, Miller KH, Ziegler C, Hertz R, Hanna N, Dragun AE.

Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):1009-16. doi: 10.1016/j.ijrobp.2016.02.007. Epub 2016 Feb 6.

PMID:
27105719
9.

Pedigree analysis for the genetic management of group-living species.

Jiménez-Mena B, Schad K, Hanna N, Lacy RC.

Ecol Evol. 2016 Apr 2;6(10):3067-78. doi: 10.1002/ece3.1831. eCollection 2016 May.

10.

Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery.

Katz SC, Point GR, Cunetta M, Thorn M, Guha P, Espat NJ, Boutros C, Hanna N, Junghans RP.

Cancer Gene Ther. 2016 May;23(5):142-8. doi: 10.1038/cgt.2016.14. Epub 2016 Apr 15.

PMID:
27080226
11.

Neonatal Marfan Syndrome: Report of a Case with an Inherited Splicing Mutation outside the Neonatal Domain.

Le Gloan L, Hauet Q, David A, Hanna N, Arfeuille C, Arnaud P, Boileau C, Romefort B, Benbrik N, Gournay V, Joram N, Baron O, Isidor B.

Mol Syndromol. 2016 Feb;6(6):281-6. doi: 10.1159/000443867. Epub 2016 Feb 2.

PMID:
27022329
12.

A Cross-Cultural Study of the Cognitive Model of Depression: Cognitive Experiences Converge between Egypt and Canada.

Beshai S, Dobson KS, Adel A, Hanna N.

PLoS One. 2016 Mar 24;11(3):e0150699. doi: 10.1371/journal.pone.0150699. eCollection 2016.

13.

Improving the ultrasound detection of isolated fetal limb abnormalities.

Andrikopoulou M, Vahanian SA, Chavez MR, Murphy J, Hanna N, Vintzileos AM.

J Matern Fetal Neonatal Med. 2016 Mar 29:1-4. [Epub ahead of print]

PMID:
26932755
14.

Development of a Symptom Management Intervention: Qualitative Feedback From Advanced Lung Cancer Patients and Their Family Caregivers.

Mosher CE, Ott MA, Hanna N, Jalal SI, Champion VL.

Cancer Nurs. 2016 Feb 26. [Epub ahead of print]

PMID:
26925990
15.

Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014.

Adra N, Althouse SK, Liu H, Brames MJ, Hanna NH, Einhorn LH, Albany C.

Ann Oncol. 2016 May;27(5):875-9. doi: 10.1093/annonc/mdw045. Epub 2016 Feb 9.

PMID:
26861605
16.

The dosimetric impact of image guided radiation therapy by intratumoral fiducial markers.

Yu S, Lawrenson L, Wei R, Sehgal V, Hanna N, Kuo J, Daroui P, Ramsinghani N, Al-Ghazi M.

Pract Radiat Oncol. 2015 Nov 14. pii: S1879-8500(15)00406-3. doi: 10.1016/j.prro.2015.11.007. [Epub ahead of print]

PMID:
26852174
17.

Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.

Adra N, Albany C, Brames MJ, Case-Eads S, Johnson CS, Liu Z, Fausel CA, Breen T, Hanna NH, Hauke RJ, Picus J, Einhorn LH.

Support Care Cancer. 2016 Jul;24(7):2837-42. doi: 10.1007/s00520-016-3100-y. Epub 2016 Feb 2.

PMID:
26838019
18.

Lung cancer screening: what do long-term smokers know and believe?

Carter-Harris L, Ceppa DP, Hanna N, Rawl SM.

Health Expect. 2015 Dec 23. doi: 10.1111/hex.12433. [Epub ahead of print]

PMID:
26701339
19.

The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.

Asare EA, Compton CC, Hanna NN, Kosinski LA, Washington MK, Kakar S, Weiser MR, Overman MJ.

Cancer. 2016 Jan 15;122(2):213-21. doi: 10.1002/cncr.29744. Epub 2015 Oct 27.

PMID:
26506400
20.

Efficacy of midtrimester short cervix interventions is conditional on intraamniotic inflammation.

Kiefer DG, Peltier MR, Keeler SM, Rust O, Ananth CV, Vintzileos AM, Hanna N.

Am J Obstet Gynecol. 2016 Feb;214(2):276.e1-6. doi: 10.1016/j.ajog.2015.09.006. Epub 2015 Sep 11.

PMID:
26364833
Items per page

Supplemental Content

Write to the Help Desk